from Lake Street issued a price target of $10.00 for XAIR on 2026-09-01 12:41:46.The adjusted price target was set to $10.00.At the time of the announcement, XAIR was trading at $3.6264.The overall price target consensus is at $1.00 with high price of $1.00, low price of $1.00, and median price is at $1.00.XAIR currently trades...
Salim Syed from Mizuho Securities issued a price target of $53.00 for ASMB on 2026-09-01 11:41:57.The...
Lake Street analyst issues BUY recommendation for XAIR on September 1, 2026 12:41PM ET. XAIR was...
Edward Nash from Canaccord Genuity issued a price target of $10.00 for ACRS on 2026-09-01 10:21:48.The...
Scotiabank analyst issues OUTPERFORM recommendation for PPTA on September 1, 2026 11:01AM ET. PPTA was trading...
from Lake Street issued a price target of $10.00 for XAIR on 2026-09-01 12:41:46.The adjusted price target was set to $10.00.At the time of the announcement, XAIR was trading at...
Salim Syed from Mizuho Securities issued a price target of $53.00 for ASMB on 2026-09-01 11:41:57.The adjusted price target was set to $53.00.At the time of the announcement, ASMB was...
Edward Nash from Canaccord Genuity issued a price target of $10.00 for ACRS on 2026-09-01 10:21:48.The adjusted price target was set to $10.00.At the time of the announcement, ACRS was...
from Needham issued a price target of $90.00 for RDVT on 2026-09-01 10:08:24.The adjusted price target was set to $90.00.At the time of the announcement, RDVT was trading at $73.16.The...
Edward Tenthoff from Piper Sandler issued a price target of $25.00 for CAPR on 2026-09-01 09:19:02.The adjusted price target was set to $25.00.At the time of the announcement, CAPR was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
